Arcus Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
18 Mar 24 | SellUS$240,941 | Jennifer Jarrett | Individual | 13,449 | US$18.62 | |
29 Jan 24 | BuyUS$319,999,995 | Gilead Sciences, Inc. | Company | 15,238,095 | US$21.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 26,335 | 0.0282% |
Private Companies | 4,198,244 | 4.5% |
Individual Insiders | 5,729,223 | 6.14% |
Public Companies | 30,061,124 | 32.2% |
Institutions | 53,286,585 | 57.1% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
30,061,124 | US$435.0m | 103% | no data | |||
9,900,341 | US$143.3m | -1.34% | no data | |||
4,904,513 | US$71.0m | 15.7% | no data | |||
4,791,244 | US$69.3m | 2.36% | no data | |||
4,779,269 | US$69.2m | 1.07% | no data | |||
3,731,279 | US$54.0m | 1,210% | no data | |||
3,433,870 | US$49.7m | 0% | no data | |||
2,883,657 | US$41.7m | 178% | 0.4% | |||
1,914,932 | US$27.7m | 149% | 0.06% | |||
1,621,409 | US$23.5m | 1.68% | no data | |||
1,612,077 | US$23.3m | 0% | 22.01% | |||
1,602,200 | US$23.2m | 0% | 1.14% | |||
1,427,920 | US$20.7m | 0.48% | no data | |||
1,201,021 | US$17.4m | -26.5% | no data | |||
1,171,968 | US$17.0m | 2.61% | no data | |||
1,151,128 | US$16.7m | -2.94% | 0.01% | |||
957,304 | US$13.9m | 0% | 0.56% | |||
869,790 | US$12.6m | 0% | 3.84% | |||
775,996 | US$11.2m | 27.8% | no data | |||
685,025 | US$9.9m | 26.9% | 0.01% | |||
586,792 | US$8.5m | 4.57% | no data | |||
547,474 | US$7.9m | 0% | 0.23% | |||
513,498 | US$7.4m | -2.13% | no data | |||
511,850 | US$7.4m | 1.35% | no data | |||
493,276 | US$7.1m | 0% | no data |